Results 21 to 30 of about 1,157 (167)

Blocked D phenomenon implicated in a diagnostic dilemma in RhD-hemolytic disease affecting twins: case report and review of literature [PDF]

open access: yesThe Turkish Journal of Pediatrics
Background. The Rh blood group system is the most common cause of hemolytic disease of the fetus and newborn (HDFN). Rh antigens are fully expressed at birth unlike ABO antigens which are weakly expressed.
Abid Ali   +3 more
doaj   +2 more sources

Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus [PDF]

open access: yesIranian Journal of Immunology, 2023
Several cases of the hemolytic disease of the fetus and newborn (HDFN) caused by immunoglobulin G (IgG) anti-M antibodies have been reported, in which almost all the HDFN-associated anti-M were warmly reacting.
Yan-Lian Liang   +10 more
doaj   +1 more source

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

open access: yesBMC Pregnancy and Childbirth
Background Hemolytic disease of the fetus and newborn (HDFN) is a condition due to maternal blood group antibodies targeting antigens in fetal red blood cells, with significant prenatal/perinatal morbidity and mortality.
Mário Dias Corrêa Júnior   +5 more
doaj   +2 more sources

Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn. [PDF]

open access: yesJ Clin Pharmacol
Abstract Nipocalimab, a neonatal Fc receptor (FcRn) blocker, is under evaluation for severe hemolytic disease of the fetus and newborn (HDFN). In the Phase 2 UNITY trial, weekly intravenous antenatal treatment with nipocalimab at dose regimens of 30 and 45 mg/kg prevented fetal anemia requiring intrauterine transfusion (IUT) in 54% of high‐risk ...
Zhou J   +8 more
europepmc   +2 more sources

Blood immunological analysis of hemolytic disease of the fetus and newborn caused by Rh deletion type D--

open access: yesZhongguo shuxue zazhi, 2023
Objective To analyze the causes of a case of hemolytic disease of the fetus and newborn (HDFN),and investigate the genetic background of maternal Rh deletion D--formation.
Yiman ZHAO   +5 more
doaj   +1 more source

History and current standard of postnatal management in hemolytic disease of the fetus and newborn [PDF]

open access: yes, 2023
Since the discovery of the Rh blood group system in 1940, a greater understanding of hemolytic disease of the fetus and newborn (HDFN) was gained. In the years thereafter, researchers and clinicians came to the current understanding that fetal and ...
Hulzebos, Christian   +5 more
core   +3 more sources

Case series of severe fetal hemolysis in Rh-C-negative mother

open access: yesGlobal Journal of Transfusion Medicine, 2020
Anti-Rh(c) antibody is the third most common cause of severe hemolytic disease of the fetus and newborn (HDFN). The widespread use of anti-D immunoglobulin has led to arelative increase in the importance of non-RhD isoimmunization as a cause of HDFN. The
Toshniwal Pramod   +3 more
doaj   +1 more source

Global, Regional and National Burden of Hemolytic Disease and Other Neonatal Jaundice, 1980/90‐2021, and Projections to 2050: A Global Burden of Disease Study 2021 [PDF]

open access: yesHealth Sci Rep
ABSTRACT Background and Aims Hemolytic disease of the fetus and newborn and other forms of neonatal jaundice remain important causes of morbidity and mortality among children under five worldwide. Despite improvements in prevention and treatment such as Rh screening, phototherapy, and exchange transfusion, the burden remains uneven across regions. This
Mulugeta C   +7 more
europepmc   +2 more sources

Hemolytic disease of the fetus and newborn due to multiple alloantibodies in pregnancy

open access: yesAsian Journal of Transfusion Science, 2020
Immune hemolytic disease of the fetus and newborn is a condition in which there is the premature destruction of fetal or neonatal red cells due to maternal alloantibody against red cell antigen inherited from father.
Vidushi Gupta   +2 more
doaj   +1 more source

Analysis of ABO system hemolytic disease of the fetus and newborn in 1 040 cases and its influencing factors

open access: yesZhongguo shuxue zazhi, 2023
Objective To analyze ABO system hemolytic disease of the fetus and newborn (HDFN) and its influencing factors in Obstetrics Department of our hospital.
Shuling DONG   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy